Asia Deal Watch: Takeda, KSQ Take CRISPR Approach To T-Cell Oncology Therapy

 
• By Ian Haydock, Joseph Haas, and Jung Won Shin
  
Asia Deal Watch
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business